Chin-Yu Lin

Title: Chin-Yu Lin: Innovator in Cancer Treatment

Introduction

Chin-Yu Lin is a prominent inventor based in Redwood City, CA (US). He has made significant contributions to the field of cancer treatment, particularly in the development of therapies targeting B-cell lymphoma and HER inhibitors. With a total of 3 patents, his work has the potential to impact many lives.

Latest Patents

Chin-Yu Lin's latest patents include innovative approaches to cancer treatment. One patent focuses on the treatment of CD20-positive B-cell lymphoma with obinutuzumab, emphasizing the importance of administration speed. Another patent discusses predicting responses to HER inhibitors, detailing the use of low HER3 as a selection criterion for treatment. It also highlights the significance of a high HER2:HER3 ratio for treating cancer patients, such as those with ovarian cancer, using HER inhibitors like pertuzumab. Additionally, it describes the use of high HER3 as a criterion for treating patients with chemotherapeutic agents, such as gemcitabine.

Career Highlights

Throughout his career, Chin-Yu Lin has worked with notable companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in cancer research and treatment.

Collaborations

Chin-Yu Lin has collaborated with several professionals in his field, including Lukas C. Amler and Merrill Birkner. These collaborations have likely enhanced his research and development efforts.

Conclusion

Chin-Yu Lin is a dedicated inventor whose work in cancer treatment showcases his innovative spirit and commitment to improving patient outcomes. His patents reflect a deep understanding of the complexities of cancer therapy, and his contributions are poised to make a lasting impact in the medical field.